Motus GI (MOTS) Coverage Initiated by Analysts at Piper Jaffray Companies

Stock analysts at Piper Jaffray Companies began coverage on shares of Motus GI (NASDAQ:MOTS) in a research note issued to investors on Sunday. The firm set an “overweight” rating and a $7.00 price target on the stock. Piper Jaffray Companies’ price objective would indicate a potential upside of 45.53% from the stock’s current price.

Shares of Motus GI (MOTS) opened at $4.81 on Friday. The stock has a market capitalization of $74.91 and a P/E ratio of -6.41. Motus GI has a 52-week low of $3.75 and a 52-week high of $5.30.

In other Motus GI news, CEO Mark Pomeranz acquired 8,000 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was bought at an average cost of $5.00 per share, for a total transaction of $40,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman David P. Hochman acquired 115,000 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was acquired at an average price of $5.00 per share, with a total value of $575,000.00. The disclosure for this purchase can be found here. Insiders purchased 1,175,000 shares of company stock valued at $5,875,000 over the last quarter.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at

About Motus GI

Motus GI Holdings, Inc is a medical technology company. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure.

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with's FREE daily email newsletter.

Leave a Reply